Therefore, CD10 constitutes a canonical element of current subclassification and prognostic algorithms in diffuse large B cell lymphoma (DLBCL), where its expression generally predicts more favorable outcomes [36]. This evidence concerns the gene MME and diffuse large B-cell lymphoma.